Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Molecular Cancer
Published in: Molecular Cancer 1/2016

Open Access 01-12-2016 | Erratum

Erratum to: ‘Hedgehog signaling: modulation of cancer properties and tumor microenvironment’

Authors: Ann Hanna, Lalita A. Shevde

Published in: Molecular Cancer | Issue 1/2016

Login to get access

Excerpt

Unfortunately, the original version of this article [1] contained errors. The words “properties” and microenvironment” have been spelt incorrectly in the title. The title should read as follows: …
Literature
1.
Metadata
Title
Erratum to: ‘Hedgehog signaling: modulation of cancer properties and tumor microenvironment’
Authors
Ann Hanna
Lalita A. Shevde
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2016
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/s12943-016-0522-6

Other articles of this Issue 1/2016

Molecular Cancer 1/2016 Go to the issue

Research

Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer

Research

Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma

Research

Esculetin induces antiproliferative and apoptotic response in pancreatic cancer cells by directly binding to KEAP1

Research

Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism

Research

MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α

Review

Essential role of miRNAs in orchestrating the biology of the tumor microenvironment
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits